Clinicopathological analysis showed that both LOX and HIF-1α expression are significantly associated with tumor FIGO classification (p=0.035 and p=0.032), tumor size (p=0.033 and p=0.032) and lymph node metastasis (p=0.016 and p=0.028, respectively) (Table II). Here, LOX is linked to neoplasm.